Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 3/20 | 0.35 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.35 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.35 |
| ▸ | WEE1 | P30291 | 1/20 | 0.32 |
| ▸ | ACACA | Q13085 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22243987 | 0.98 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10WEE1ACACA | |
| SCHEMBL22243815 | 0.98 | WEE1 (0.33) | PLA2G2APLA2G4APLA2G10WEE1ACACA | |
| SCHEMBL22243699 | 0.97 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10WEE1ACACA | |
| SCHEMBL22243705 | 0.97 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10WEE1ACACA | |
| SCHEMBL22243713 | 0.95 | KMT2A (0.34) | PLA2G2APLA2G4AWEE1ACACAGAA | |
| SCHEMBL22243861 | 0.94 | PLA2G2A (0.35) | PLA2G2APLA2G4APLA2G10WEE1ACACA | |
| SCHEMBL22243858 | 0.92 | PLA2G2A (0.34) | PLA2G2APLA2G4APLA2G10WEE1ACACA | |
| SCHEMBL22243988 | 0.92 | MEN1 (0.37) | PLA2G2APLA2G4APLA2G10WEE1ACACA | |
| SCHEMBL22243878 | 0.91 | WEE1 (0.33) | PLA2G2APLA2G4APLA2G10WEE1ACACA | |
| SCHEMBL22243989 | 0.90 | PLA2G2A (0.36) | PLA2G2APLA2G4APLA2G10WEE1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200231580-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING SAME | DOOSAN CORPORATION (KR) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200231580-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING SAME | SLCO4C1, SLCO2A1, POU2F1 | PLA2G2A 3976/4885PLA2G4A 4028/4885PLA2G10 4024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.